Clinical Trial Update: Implementing Circulating Tumor DNA Analysis at Initial Diagnosis to Improve Management of Advanced NSCLC Patients [NA]

View source ↗

Summary

The trial has completed and evaluated circulating tumor DNA analysis at initial diagnosis to guide management in patients with advanced non-small cell lung canc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Institut Bergonié | Conditions: Non Small Cell Lung Cancer, Advanced Solid Tumor | NA | Status: COMPLETED